$VRTX never stopped adding here and will continue to do so. The market will continue to ignore pipeline until CTX001 is approved which is near certain at this point. It will take some as it’s a first in class treatment but it should cement vertex as the leader in gene editing which I already believe they are. CF will continue to add to the cash pile for furthering the pipeline through organic and inorganic growth. R/R does not get much better than this in bio
2
4
4 Likes